Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants

• Bernard Vanhove,
• Stéphane Marot,
• Ray T. So,
• Benjamin Gaborit,
• Benjamin Gaborit,
• Gwénaëlle Evanno,
• Isabelle Malet,
• Guillaume Lafrogne,
• Edwige Mevel,
• Carine Ciron,
• Pierre-Joseph Royer,
• Elsa Lheriteau,
• François Raffi,
• François Raffi,
• Roberto Bruzzone,
• Roberto Bruzzone,
• Chris Ka Pun Mok,
• Chris Ka Pun Mok,
• Odile Duvaux,
• Anne-Geneviève Marcelin,
• Vincent Calvez

Affiliations

Bernard Vanhove

Xenothera, Nantes, France

Stéphane Marot

Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM) 1136, Institut Pierre Louis d’Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France

Ray T. So

Hong Kong University (HKU)-Pasteur Research Pole, School of Public Health, Li Ka Shing (LKS) Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR, China

Benjamin Gaborit

Department of Infectious Disease, Nantes University Hospital, Nantes, France

Benjamin Gaborit

Institut National de la Santé et de la Recherche Médicale (INSERM) CIC1413, Nantes University Hospital, Nantes, France

Gwénaëlle Evanno

Xenothera, Nantes, France

Isabelle Malet

Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM) 1136, Institut Pierre Louis d’Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France

Guillaume Lafrogne

Xenothera, Nantes, France

Edwige Mevel

Xenothera, Nantes, France

Carine Ciron

Xenothera, Nantes, France

Pierre-Joseph Royer

Xenothera, Nantes, France

Elsa Lheriteau

Xenothera, Nantes, France

François Raffi

Department of Infectious Disease, Nantes University Hospital, Nantes, France

François Raffi

Institut National de la Santé et de la Recherche Médicale (INSERM) CIC1413, Nantes University Hospital, Nantes, France

Roberto Bruzzone

Hong Kong University (HKU)-Pasteur Research Pole, School of Public Health, Li Ka Shing (LKS) Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR, China

Roberto Bruzzone

Department of Cell Biology and Infection, Institut Pasteur, Paris, France

Chris Ka Pun Mok

Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China

Chris Ka Pun Mok

The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China

Odile Duvaux

Xenothera, Nantes, France

Anne-Geneviève Marcelin

Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM) 1136, Institut Pierre Louis d’Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France

Vincent Calvez

Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (INSERM) 1136, Institut Pierre Louis d’Epidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié Salpêtrière Hospital, Department of Virology, Paris, France